Compare SURG & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SURG | IRIX |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 25.4M |
| IPO Year | N/A | 1996 |
| Metric | SURG | IRIX |
|---|---|---|
| Price | $0.87 | $1.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 450.6K | 114.0K |
| Earning Date | 03-24-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $50,372,555.00 | ★ $50,647,000.00 |
| Revenue This Year | $3.78 | $9.61 |
| Revenue Next Year | $113.46 | $8.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $0.86 | $0.78 |
| 52 Week High | $3.47 | $1.65 |
| Indicator | SURG | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 23.52 | 43.41 |
| Support Level | $0.86 | $1.35 |
| Resistance Level | $1.09 | $1.52 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 1.75 | 7.14 |
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.